Sameer Doshi

Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications

Min Zhu, Benjamin Wu, Christian Brandl et al. · Clinical Pharmacokinetics · 2016 · 203 citations

Bispecific T-cell Engager, Tumor Immunology, Cancer Immunosurveillance +8

Volume Reconstruction Techniques Improve the Correlation Between Histological and in vivo Tumor Volume Measurements in Mouse Models of Human Gliomas

Karl Schmidt, Mateo Ziu, Nils Ole Schmidt et al. · Journal of Neuro-Oncology · 2004 · 102 citations

Positron Emission Tomography, Neuro-oncology, Tissue Imaging +13

Population Pharmacokinetic Analysis of Denosumab in Patients with Bone Metastases from Solid Tumours

Leonid Gibiansky, Liviawati Sutjandra, Sameer Doshi et al. · Clinical Pharmacokinetics · 2012 · 90 citations

Oncology, Metronomic Therapy, Pharmacology +6

Pharmacodynamics-Mediated Drug Disposition (PDMDD) and Precursor Pool Lifespan Model for Single Dose of Romiplostim in Healthy Subjects

Yow‐Ming Wang, Wojciech Krzyżański, Sameer Doshi et al. · The AAPS Journal · 2010 · 79 citations

Healthy Subjects, Pharmacological Study, Longevity +6

Pituitary Adenylyl Cyclase-Activating Polypeptide Stimulates DNA Synthesis But Delays Maturation of Oligodendrocyte Progenitors

Matthew Lee, Vincent Lelièvre, Paul Zhao et al. · Journal of Neuroscience · 2001 · 64 citations · Full text